Statement Of Financial Position [Abstract]

STADA Arzneimittel AG - Filing #6743034

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
540,239 EUR
491,867 EUR
Investments accounted for using equity method
2,939 EUR
2,710 EUR
Deferred tax assets
36,919 EUR
44,198 EUR
Cash and cash equivalents
526,482 EUR
266,001 EUR
206,039 EUR
Assets
5.756.945 EUR
5.258.197 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
162,090 EUR
162,090 EUR
Share premium
514,206 EUR
514,206 EUR
Treasury shares
1,403 EUR
1,403 EUR
Equity attributable to owners of parent
1.136.261 EUR
929,706 EUR
Non-controlling interests
79,283 EUR
87,645 EUR
Equity
1,403 EUR
1.215.544 EUR
906,037 EUR
10,343 EUR
1.136.260 EUR
79,283 EUR
514,206 EUR
455,012 EUR
162,090 EUR
87,645 EUR
929,706 EUR
162,090 EUR
776,985 EUR
1,403 EUR
528,096 EUR
514,206 EUR
1.017.351 EUR
5,924 EUR
1.080.342 EUR
115,126 EUR
400,937 EUR
1.195.468 EUR
514,206 EUR
108,000 EUR
806,278 EUR
1,403 EUR
162,090 EUR
Liabilities [abstract]
Deferred tax liabilities
170,320 EUR
139,527 EUR
Liabilities included in disposal groups classified as held for sale
- EUR
- EUR
Equity and liabilities
5.756.945 EUR
5.258.197 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.